Minor haemoptysis seen in the community
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Minimal haemoptysis, stable patient, bleeding stopped
Not a laboratory test
- Contrast-enhanced chest CT (CT angiography): first-line test according to the French reference document; failing that, PA and lateral chest X-ray, then CT if it finds no cause.
Laboratory tests
- FBC
- Serum creatinine with eGFR
- PT, aPTT (if known coagulation disorder or anticoagulant)if neededHistory of haemostasis disorder or anticoagulant treatment: assess coagulation [3]. On a VKA, request the INR (see the “Treatment: vitamin K antagonist (VKA)” page). The coagulation tests (FBC, PT, INR, aPTT, anti-Xa activity or specific assay on a direct oral anticoagulant) look for a coagulation disorder or anticoagulant overdose, which cannot by itself be the cause of the haemoptysis [4].
- ASTif needednon-French guidelineIn the United States, the American Family Physician includes a full biochemical panel among the tests for every patient, notably because liver disease can disturb platelets and coagulation [3]. The French teaching reference does not cite it in its coagulation tests [4], hence the option, limited to the relevant patient group.
- ALTif needednon-French guidelineIn the United States, the American Family Physician includes a full biochemical panel among the tests for every patient, notably because liver disease can disturb platelets and coagulation [3]. The French teaching reference does not cite it in its coagulation tests [4], hence the option, limited to the relevant patient group.
- Bilirubinif needednon-French guidelineIn the United States, the American Family Physician includes a full biochemical panel among the tests for every patient, notably because liver disease can disturb platelets and coagulation [3]. The French teaching reference does not cite it in its coagulation tests [4], hence the option, limited to the relevant patient group.
- Acid-fast bacilli (mycobacteria) in sputum, 2 to 3 samples (if tuberculosis possible)if neededFever, weight loss, productive cough, history of tuberculosis: sputum examination for acid-fast bacilli (and IGRA depending on the context) [3]. Tuberculosis is the leading cause of haemoptysis worldwide [3]. Write “AFB testing” (acid-fast bacilli): a standard sputum culture does not include it. First-line, 2 to 3 samples, not necessarily on 3 consecutive days (possible within 24 hours); a negative direct examination does not rule out the diagnosis [5]. Symptomatic patient suspected of pulmonary tuberculosis: samples taken in hospital, in a single room with airborne isolation [5].
- Sputum culture (if respiratory infection suspected)if needednon-French guidelineSuspected infectious cause (bronchitis, pneumonia, abscess, infected bronchiectasis): sputum examination with Gram stain and culture [3].
- Aspergillus serology (if cavity, tuberculosis sequelae)if neededPossible chronic pulmonary aspergillosis (cleaned-out tuberculous cavity, cavity): Aspergillus serology, and in some cases Aspergillus antigen and mycological examination of sputum [4].
- NT-proBNP (if heart failure possible)if needednon-French guidelineSuspected congestive heart failure as the cause of the haemoptysis [3].
- ANCAif needednon-French guidelineSuspected immunological disease or vasculitis (synovitis, skin signs of autoimmune disease): antibodies (ANCA, antinuclear, anti-dsDNA, anti-glomerular basement membrane, anticardiolipin) and inflammatory markers [3].
- CRPif needednon-French guidelineSuspected immunological disease or vasculitis (synovitis, skin signs of autoimmune disease): antibodies (ANCA, antinuclear, anti-dsDNA, anti-glomerular basement membrane, anticardiolipin) and inflammatory markers [3].
Sources (9)
- Earwood JS, Thompson TD. Hemoptysis: evaluation and management. Am Fam Physician. 2015;91(4):243-249.
- Abdulmalak C, Cottenet J, Beltramo G, et al. Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database. Eur Respir J. 2015;46(2):503-11.
- O'Gurek D, Choi HYJ. Hemoptysis: evaluation and management. Am Fam Physician. 2022;105(2):144-151.
- Collège des enseignants de pneumologie (CEP, SPLF). Item 205 – Hémoptysie. Référentiel pour la préparation des épreuves dématérialisées nationales, 9e édition, 2026.
- Collège des enseignants de pneumologie (CEP, SPLF). Item 159 – Tuberculose de l'adulte et de l'enfant. Référentiel pour la préparation des épreuves dématérialisées nationales, 9e édition, 2026.
- National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NICE guideline NG12, 23 juin 2015, mise à jour le 15 avril 2026.
- National Institute for Health and Care Excellence. Tuberculosis. NICE guideline NG33, 13 janvier 2016, mise à jour le 16 février 2024.
- Cancer Council Victoria, Department of Health Victoria. Optimal care pathway for people with lung cancer. 2e édition, juin 2021, mise à jour mineure de juillet 2025.
- Ittrich H, Bockhorn M, Klose H, Simon M. The diagnosis and treatment of hemoptysis. Dtsch Arztebl Int. 2017;114(21):371-381.